{"id":42308,"date":"2025-10-14T11:54:27","date_gmt":"2025-10-14T06:24:27","guid":{"rendered":"https:\/\/dailynewsindia.co.in\/index.php\/2025\/10\/14\/chandan-healthcare-limited-board-approves-inr-104-13-cr-fund-raise-via-pref-issue-forges-strategic-partnership-with-jeena-sikho-lifecare-limited\/"},"modified":"2025-10-14T11:54:27","modified_gmt":"2025-10-14T06:24:27","slug":"chandan-healthcare-limited-board-approves-inr-104-13-cr-fund-raise-via-pref-issue-forges-strategic-partnership-with-jeena-sikho-lifecare-limited","status":"publish","type":"post","link":"https:\/\/dailynewsindia.co.in\/index.php\/2025\/10\/14\/chandan-healthcare-limited-board-approves-inr-104-13-cr-fund-raise-via-pref-issue-forges-strategic-partnership-with-jeena-sikho-lifecare-limited\/","title":{"rendered":"Chandan Healthcare Limited Board Approves INR 104.13 Cr Fund Raise Via Pref Issue; Forges Strategic Partnership with Jeena Sikho Lifecare Limited"},"content":{"rendered":"
\n

Lucknow (Uttar Pradesh) [India], October 14:<\/strong> Chandan Healthcare Limited (NSE \u2013 CHANDAN), \u2013 Chandan Healthcare Limited, one of the leading players in North India\u2019s diagnostics and healthcare services sector, announced two significant developments that mark a new phase of strategic growth, approval of a \u20b9104.13 Cr fund raises through a preferential issue of warrants and an exclusive nationwide diagnostic partnership with Jeena Sikho Lifecare Limited.<\/p>\n

The Board of Directors of Chandan Healthcare Limited has approved the issuance of\u00a0up to 44,50,000 fully convertible equity warrants\u00a0on a\u00a0preferential basis\u00a0at an issue price of\u00a0\u20b9\u00a0234 per warrant, aggregating to approximately\u00a0\u20b9\u00a0104.13\u00a0Cr, subject to shareholder and regulatory approvals.<\/p>\n

Each warrant will be convertible into one fully paid-up equity share of face value\u00a0\u20b910. The issue has been structured to include both\u00a0promoter group participation\u00a0and\u00a0strategic institutional investors, underscoring strong market confidence in the company\u2019s future growth trajectory.<\/p>\n

Allotment Summary<\/p>\n

\u2022\u00a0Promoter & Promoter Group:\u00a04,75,000 warrants (including Mr. Amar Singh \u2013 Promoter & Managing Director, Mrs. Asmita Singh \u2013 Promoter & Managing Director, and other\u00a0Promoter Groupmembers)<\/p>\n

\u2022\u00a0Non-Promoter Group:\u00a039,75,000 warrants (including Jeena Sikho Lifecare Limited \u2013 18,00,000 warrants, NEGEN Undiscovered Value Fund, NEGEN Capital Services Private Limited, and other institutional and individual investors)<\/p>\n

Chandan Healthcare has also entered into an\u00a0exclusive strategic partnership\u00a0with\u00a0Jeena Sikho Lifecare Limited, one of India\u2019s leading Ayurvedic healthcare providers, to establish\u00a0diagnostic centres across all existing and upcoming Jeena Sikho hospitals and clinics across India.<\/p>\n

Key Highlights of the Collaboration:<\/p>\n

\u2022\u00a0Exclusive Partnership:\u00a0Chandan will act as the exclusive diagnostic partner for all Jeena Sikho hospitals and clinics across 23 states and 100+ cities.<\/p>\n

\u2022\u00a0Comprehensive Services:\u00a0The company will provide\u00a0end-to-end pathology and radiology solutions\u00a0for both IPD and OPD patients.<\/p>\n

\u2022\u00a0Enhanced Accessibility:\u00a0The initiative aims to expand access to\u00a0high-quality, affordable, and tech-enabled diagnostic servicesacross India, aligning with both organizations shared vision of holistic healthcare delivery.<\/p>\n

This collaboration significantly expands Chandan Healthcare\u2019s national footprint, strengthening its position as a leading integrated healthcare provider with presence across diagnostics, hospitals, and retail pharmacy.<\/p>\n

Commenting on the development, Mr.\u00a0Amar Singh,\u00a0Promoter and Managing Director of Chandan Healthcare Limited, said,\u00a0\u201cBoth the fund raise and the strategic partnership with Jeena Sikho mark pivotal steps in Chandan\u2019s journey toward becoming one of India\u2019s most trusted integrated healthcare brands. The strong response from investors reflects deep confidence in our business model and growth strategy.<\/p>\n

A major part of the funds raised will be deployed towards\u00a0organic and inorganic expansion, including setting up\u00a0new diagnostic laboratories, upgrading infrastructure, and strengthening\u00a0working capital\u00a0to support our fast-growing operations. This infusion will enable us to enhance capacity, deepen market presence, and accelerate our pan-India growth momentum.<\/p>\n

The collaboration with Jeena Sikho Lifecare Limited represents a strong synergy between Chandan\u2019s advanced diagnostic expertise and Jeena Sikho\u2019s deep-rooted presence in Ayurvedic healthcare. Together, we aim to bridge the gap between modern medicine and traditional wellness, creating a holistic model of patient care.<\/p>\n

This partnership will significantly expand our national footprint, enabling us to bring world-class, technology-driven diagnostic services to more regions across India, and make high-quality, affordable healthcare accessible to every individual.\u201d<\/p>\n

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Lucknow (Uttar Pradesh) [India], October 14: Chandan Healthcare Limited (NSE \u2013 CHANDAN), \u2013 Chandan Healthcare Limited, one of the leading players in North India\u2019s diagnostics and healthcare services sector, announced two significant developments that mark a new phase of strategic growth, approval of a \u20b9104.13 Cr fund raises through a preferential issue of warrants and…<\/p>\n

Read More “Chandan Healthcare Limited Board Approves INR 104.13 Cr Fund Raise Via Pref Issue; Forges Strategic Partnership with Jeena Sikho Lifecare Limited”<\/span> »<\/a><\/p>\n","protected":false},"author":1,"featured_media":42309,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[54],"class_list":["post-42308","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business"],"_links":{"self":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts\/42308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/comments?post=42308"}],"version-history":[{"count":0,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts\/42308\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/media\/42309"}],"wp:attachment":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/media?parent=42308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/categories?post=42308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/tags?post=42308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}